Drug Prices Are NOT Skyrocketing—They’re Barely Growing at All
Too many politicians and journalists remain committed to the false narrative of “skyrocketing” and “soaring” drug prices.
By contrast, IQVIA data reveal that list prices for brand-name drugs grew by less than 6% in 2018. What’s more, net prices (after rebates and discounts) increased by only 1.5%. The 2018 figures mark the fourth consecutive year that net drug prices have grown by low-single-digit amounts.
